Best possible anesthetic care for all your patients
Our goal is to help you reduce postoperative complications, minimize agent usage and give you more time to treat and care for your patients during surgery. You and your patients, from neonates to morbidly obese, can benefit from Maquet Flow-i®.
Invitation to interactive low and minimal-flow anesthesia course, 16-17 Nov in Gent, Belgium
Welcome to a 1.5 day course for anesthesiologists, including theoretical presentations, hands-on animal workshops and demo during live surgery. Seats are limited so registration is on a first come, first served basis.
ICU ventilation performance and anesthesia delivery - all in one
When treating high-risk patients with pulmonary disease or compromised pulmonary function, you need an anesthesia machine with superior ventilation performance. Based on our heritage and the core technology of the Servo ventilator platform, Flow-i is designed to handle these common ventilatory challenges.
Easy steps to lung recruitment in the OR
Atelectasis affects over 90% of patients undergoing surgery, regardless of gender, age, health condition or length of surgery, showing the importance of protecting patients’ lungs.
Lung recruitment maneuvers have become the tool of choice to counter atelectasis. Still, many clinicians find it somewhat complicated and time-comsuming to apply lung protective strategies - but it doesn't have to be.
Concerned about the risks of low-flow anesthesia? We are too.
That is why we developed Automatic Gas Control (AGC®), facilitating safe low- and minimal-flow anesthesia.
Unique O₂Guard helps reduce risk for hypoxia
Unlike hypoxic guards in conventional anesthesia machines, Flow-i´s O₂Guard® actively intervenes if the inspired oxygen concentration drops below 21%, eliminating the risk of hypoxic mixtures.
Customer voices on Automatic Gas Control
for low-flow anesthesia
"42% volatile agent savings with AGC."
Learn how Belfast hospital realized they could substantially reduce their agent consumption with AGC.
"AGC was an absolutely amazing experience, with no comparison to it."
Professor Sanuki, Hiroshima University Hospital Japan, shares his impressions.
“AGC buys us time to care for the patient, as well as time to document the patient recordings.”
Staff share their impressions after AGC was installed on 60 of their Flow-i anesthesia machines.
Reduce the cost and stress of ownership
UK hospital estimated a 33% cost savings on agent usage with Flow-i
After changing their anesthesia machine fleet to Flow-i, a UK hospital conducted a six-month retrospective comparison of anesthetic agent usage using FLOW-i versus the old technology. Flow-i was estimated to result in a 33% cost savings in agent consumption.
Improve your patient outcomes by optimized perioperative fluid management
Our technology supports your therapeutic decisions in high risk surgical patient with continuous and reliable facts.
This significant improvement has been confirmed in clinical studies  and gives you more safety in your decisions.
High quality consumables
We offer an extensive range of readily available consumables designed for highest possible patient safety and ease of use – all to help secure your everyday operations.
Patient data at your fingertips
MSync helps you to connect your Flow-i fleet to your patient monitor, HIS or patient data management system (PDMS). Clinical and patient data is transferred in real time to support clinical decision-making.
Scalable service programs
Getinge Care is our extensive and flexible service program. It ensures that your devices have the highest possible device uptime, including front line support, remote service, software updates, training and much more.
1. Tusman G, Bohm SH, Warner DO, Sprung J: Atelectasis and perioperative pulmonary complications in high-risk patients. Curr Opin Anesthesiol 2012, Feb;25:1-10
2. Salzwedel C et al., Perioperative goal-directed hemodynamic therapy based on radial arterial pulse pressure variation and continuous cardiac index trending reduces postoperative complications after major abdominal surgery: a multi-center, prospective, randomized study. Crit Care 2013; 17(5): R191.